openPR Logo
Press release

Testosterone Replacement Therapy Market to Reach an Overall Valuation of US$ 1.3 Billion by the End of 2024

11-23-2017 10:36 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Testosterone Replacement Therapy Market to Reach an Overall

The global market is expected to reach an overall valuation of US$1.3 bn by the end of 2024. This valuation is lower than that found in the year of 2015 of US2.0 bn. The market will show a negative CAGR of -4.2% over the course of the forecast period of 2016 to 2024.

Hypogonadism or more commonly known as the testosterone deficiency is a prevailing problem found in men that are aged between 40 to 79 years. Some studies also suggest that nearly 30% of the men across the globe are impacted by this testosterone deficiency problem. As the occurrence of such cases increase in number, the demand for testosterone replacement therapy is also expected soar subsequently.

Read Report Overview @ https://www.transparencymarketresearch.com/testosterone-replacement-therapy.html

Along with this major factor, another important driving factor for the growth of the global testosterone replacement therapy market is the increasing geriatric population across the world at a steady pace. This points to huge demographic target for the companies in the global testosterone replacement therapy market. It is expected that number of men reporting deficiency of testosterone will increase across the world as the number of older population will rise. In addition to these two factors, there is a growing awareness among the world population about the deficiency of testosterone and they are taking measures to tackle the problem. This will subsequently help in boosting the growth prospects of the global testosterone replacement therapy market.

However, there are some problems which are projected to cause some problems in the development of the global testosterone replacement therapy market. There is a modest level of apprehension among people about the side effects caused due to the use of the testosterone replacement therapy. Risk of developing metabolic and cardiovascular diseases is also impeding the growth of the market of testosterone replacement therapy products. There are several studies and reports which have indicated the ill effects of the therapy owing to which FDA has issued ample warnings about the possible risks. This has caused a large number of patients to see the testosterone replacement therapy in a negative shade of light.

In addition to this, the global market is nearing a cliff related to the patent approval issue. It is expected that the market for testosterone will face a problem of imminent expirations of patents and may lead to impeding the growth of the market in the coming years. However, with several drivers working in favor of the therapy, the market will witness a steady growth during the given forecast period of 2016 to 2024.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1097

Some of the key players in the global testosterone replacement therapy market include names such as Allergan Plc., AbbVie Inc., Bayer AG., Eli Lilly and Company, Endo Pharmaceuticals, Kyowa Kirin International Plc., Novartis AG., Mylan N.V., and Pfizer Inc. among others. The global market for testosterone replacement therapy is a little bit consolidate with the existence of a few big established companies and the presence of some domestic vendors that are playing their trade in the global market. Companies are now focusing on product development and innovation to enhance their market presence. Recently, Pfizer’s new drug, Mylotarg, has been approved by the U.S. Food and Drug Administration, for certain patients who suffer from acute myeloid leukemia (AML). More and more companies are inclining towards getting their products sanctioned and get into the market. This will in turn, help in intensifying the competitive market landscape of the global testosterone replacement therapy market over the course of the given forecast period of 2016 to 2024. The top five companies in the global market held over 80% of the total market share in the 2015 out of which AbbVie Inc. has come up on top as the undisputed leader.

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Testosterone Replacement Therapy Market to Reach an Overall Valuation of US$ 1.3 Billion by the End of 2024 here

News-ID: 830153 • Views: 301

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Plc

Statins Market Key Players : AstraZeneca plc, Pfizer Inc., GlaxoSmithKline plc
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients. Demand for statins is long driven by increasing healthcare awareness among common masses. In U.S., over 500,000 people suffers heart attack every year. Though cholesterol level is easy to
Programmable Logic Controller (PLC) Market -
Programmable Logic Controller (PLC) technology is not recent in the industry, and is still in usage at a great extent by manufacturing companies. Programmable Logic Controller smoothens the mechanical automation process in manufacturing units and construction buildings. Due to its dynamic development, sequential control, counters and timers, ease of programming, reliable controlling capabilities, and ease of hardware usage; Programmable Logic Controllers are also utilized in various control system areas. Browse The
Online Gambling Global Market 2018: Key Players – William Hill Plc., Paddy Pow …
Online Gambling Industry Description Wiseguyreports.Com Adds “Online Gambling -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database Online Gambling refers to betting of money online on an event with an uncertain outcome. Online gambling is similar to gambling but the difference is that online gambling is betting on sports or casino over the internet. Online gambling is not limited to playing cards. It is a
Antibacterial Drugs Market: Allergen plc, AstraZeneca plc, Bayer AG
New York, February 14: Market Research Engine has published a new report titled as “Antibacterial Drugs Market By Class (Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Macrolides, Phenicols and Pipeline Drugs) - Global Industry Analysis, Trends and Forecast 2015 - 2023” The Antibacterial Drugs market is expected to cross US$ 38 Billion by 2023 growing at a CAGR of 1.30% during the given forecast period. Browse Full Report: https://www.marketresearchengine.com/reportdetails/antibacterial-drugs-market The term Antibiotic refers to antimicrobials which are
FATEK PLC
* FATEK FBs Series PLC- The FBs-PLC has more than 300 instructions which adopts a user friendly and readable multi-input/multi-output function structure. With this multi-input instruction structure the user can derive many types of functionality which other brands of PLC’s may require the use of many instructions to achieve this. * FATEK B1/B1z Series PLC- Economical and High-Quality PLC FATEK B1/B1z Series Micro-Programmable Controllers The streamline design of SoC technology significantly reduces the hardware costs.
SANYO PLC-XP200L & PLC-XC55 Multimedia Projectors
San Diego, CA, December 5, 2008 Audio Video Supply, Inc, a San Diego distributor first in presentation technology, has introduced the new Sanyo PLC-XP200L XGA Multimedia Projector and Sanyo PLC-XC55 Portable Multimedia LCD Projector from its new product line. The Sanyo PLC-XP200L is the world’s first 4LCD optical engine, making it the brightest projector in its class. The PLC-XP200L packs 7,000 lumens produced from a 330-watt lamp. The new QuaDrive